Superstring Capital Management LP
- SEC CIK
- 0001931118
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 33
- −5 vs. Q4 2024
- Portfolio value
- $83.8M
- −$30.0M (−26.4%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ZLABZai Lab Ltd | ADR | 294,947 | $10.7M | 12.7% | −108,683−26.9% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 183,922 | $6.36M | 7.6% | −78,219−29.8% | Reduced | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 96,821 | $6.15M | 7.3% | +96,821 | New | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 160,442 | $5.44M | 6.5% | +90,848+130.5% | Added | History |
| PFEPfizer Inc | Stock | 196,164 | $4.97M | 5.9% | +196,164 | New | History |
| URGNUroGen Pharma Ltd. | COM | 423,632 | $4.69M | 5.6% | +122,426+40.6% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 774,721 | $4.64M | 5.5% | −136,144−14.9% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 819,194 | $4.57M | 5.5% | −761,551−48.2% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 237,487 | $4.26M | 5.1% | +237,487 | New | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,357,153 | $3.75M | 4.5% | −663,409−32.8% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 72,992 | $2.93M | 3.5% | −56,397−43.6% | Reduced | History |
| SVRASavara Inc | COM | 966,203 | $2.68M | 3.2% | +457,865+90.1% | Added | History |
| SMMTSummit Therapeutics Inc. | COM | 132,019 | $2.55M | 3.0% | −32,545−19.8% | Reduced | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 54,216 | $2.39M | 2.9% | +54,216 | New | History |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 241,192 | $2.29M | 2.7% | +185,963+336.7% | Added | History |
| VSTMVerastem, Inc. | COM NEW | 336,363 | $2.03M | 2.4% | +126,474+60.3% | Added | History |
| TARAProtara Therapeutics, Inc. | COM STK | 360,000 | $1.53M | 1.8% | 00.0% | Unchanged | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 43,613 | $1.46M | 1.7% | +43,613 | New | History |
| SLNOSoleno Therapeutics Inc | COM | 19,332 | $1.38M | 1.6% | +19,332 | New | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 3,815 | $1.26M | 1.5% | +2,686+237.9% | Added | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 32,145 | $1.26M | 1.5% | +32,145 | New | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 755,599 | $1.05M | 1.3% | +755,599 | New | History |
| TECXTectonic Therapeutic, Inc. | COM | 50,746 | $898.7K | 1.1% | +50,746 | New | History |
| ZBIOZenas BioPharma, Inc. | COM | 111,605 | $881.7K | 1.1% | 00.0% | Unchanged | History |
| ETNB89bio, Inc. | COM | 109,156 | $793.6K | 0.9% | −23,826−17.9% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 22,271 | $657.4K | 0.8% | +22,271 | New | – |
| CABACabaletta Bio, Inc. | COM | 458,972 | $635.7K | 0.8% | −363,321−44.2% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 11,264 | $425.3K | 0.5% | +11,264 | New | History |
| KYTXKyverna Therapeutics, Inc. | COM | 191,287 | $369.2K | 0.4% | +9,110+5.0% | Added | History |
| OCULOcular Therapeutix, Inc | COM | 42,297 | $310.0K | 0.4% | +42,297 | New | History |
| SDGRSchrodinger, Inc. | COM | 14,114 | $278.6K | 0.3% | +14,114 | New | History |
| IPSCCentury Therapeutics, Inc. | COM | 462,963 | $220.4K | 0.3% | 00.0% | Unchanged | History |
| Lakeshore Biopharma Co LtdG9845F208 | ORD SHS NEW | 30,792 | $74.5K | 0.1% | 00.0% | Unchanged | – |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| CPIXCumberland Pharmaceuticals Inc | COM | – | $211.5K |
Sold out since Q4 2024 (18)
Positions held at the end of Q4 2024 that are gone from this filing.
| Security | Class | Shares in Q4 2024 | Value in Q4 2024 | % of portfolio in Q4 2024 | History |
|---|---|---|---|---|---|
| NVCRNovoCure Ltd | ORD SHS | 286,970 | $8.55M | 7.5% | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 216,811 | $5.88M | 5.2% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 227,102 | $5.84M | 5.1% | History |
| TILInstil Bio, Inc. | COM NEW | 148,017 | $2.83M | 2.5% | History |
| PTGXProtagonist Therapeutics, Inc | COM | 68,892 | $2.66M | 2.3% | History |
| INSMINSMED Inc | COM PAR $.01 | 35,966 | $2.48M | 2.2% | History |
| FATEFate Therapeutics Inc | COM | 1,379,556 | $2.28M | 2.0% | History |
| DYNDyne Therapeutics, Inc. | COM | 73,150 | $1.72M | 1.5% | History |
| TNGXTango Therapeutics, Inc. | COM | 474,955 | $1.47M | 1.3% | History |
| KURAKura Oncology, Inc. | COM | 157,959 | $1.38M | 1.2% | History |
| INCYIncyte Corp | COM | 18,009 | $1.24M | 1.1% | History |
| ONCBeOne Medicines Ltd. | ADR | 6,365 | $1.18M | 1.0% | History |
| RZLTRezolute, Inc. | COM NEW | 123,184 | $603.6K | 0.5% | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 186,943 | $467.4K | 0.4% | History |
| EYPTEyePoint, Inc. | COM NEW | 49,375 | $367.8K | 0.3% | History |
| AXSMAxsome Therapeutics, Inc. | COM | 4,268 | $361.1K | 0.3% | History |
| LXEOLexeo Therapeutics, Inc. | COM | 52,616 | $346.2K | 0.3% | History |
| CLYMClimb Bio, Inc. | COM | 98,160 | $176.7K | 0.2% | History |